U.S. Food and Staples Retail Stock News

Vertiv Holdings Co (NYSE:VRT) has expanded its collaboration with NVIDIA to co-develop AI focused data center solutions, including an 800 volt DC power architecture. The company has also launched a production grade digital twin product designed to model and optimize AI infrastructure, often described as "AI factories." These developments relate directly to power efficiency and planning for AI heavy data centers, an area of growing focus for global operators. Vertiv comes into this news with...

Amgen (NasdaqGS:AMGN) presented new VESALIUS-CV Phase 3 data for Repatha in high-risk diabetes at the ADA 86th Scientific Sessions in 2026. The trial reported a significant reduction in major cardiovascular events for high-risk diabetic patients treated with Repatha. Results were also published in major medical journals, underscoring clinical relevance for cardiometabolic care. The findings highlight a large, underserved patient group within diabetes and obesity management where current...

Investors may be wondering whether Westlake stock still offers value at around US$87.27, or if most of the potential upside is already reflected in the current price. The stock is up 2.4% over the last week and 17.7% year to date, even though it is down 9.6% over the past month. Its 3-year and 5-year returns are 19.9% and 1.0% respectively. Recent news coverage has largely focused on the broader chemicals sector, regulatory developments, and shifting expectations around demand cycles. All of...

Wendy's (NasdaqGS:WEN) is rolling out a pickle themed menu across Canada, adding new limited time items centered on pickle flavors. The company is also launching a nationwide "Minions & Monsters" promotion that includes themed menu items and branded collectibles. These launches highlight Wendy's current focus on product variety and pop culture tie ins to engage customers and refresh its marketing. For investors tracking quick service restaurants, Wendy's sits in a crowded category where...

Wondering whether Enphase Energy at around US$50.57 is a bargain or a value trap? This article walks through what the current price really implies about the stock. The share price has been volatile, with a decline of 26.7% over the past week, a gain of 34.3% over the last month, a 49.8% gain year to date, an 11.7% gain over the past year, and larger declines of 71.8% over three years and 66.7% over five years. These swings have kept Enphase in the spotlight as investors react to shifting...

If you are wondering whether Cloudflare's share price still makes sense after a strong run in recent years, the key question now is how that price stacks up against what the business may be worth. The stock recently closed at US$219.67, with the share price down 17.2% over the past week, up 13.5% over the past month, up 12.1% year to date and up 22.2% over the past year, while the three year return sits at a very large level and the five year return is 131.8%. Recent headlines have focused...

Wondering if Entergy at around US$110.48 is offering fair value right now, or if the recent run means you might be paying up for the stock. The stock has returned 1.7% over the past week, is down 2.2% over the past month, and sits on a 17.7% year to date gain, with 37.9% over 1 year, 141.7% over 3 years, and 145.7% over 5 years. Recent coverage has focused on Entergy as a regulated electric utility, with attention on its role in regional power infrastructure and ongoing investment needs...

On June 8, 2026, Brady Corporation announced that long‑time CEO Russell Shaller retired and was succeeded the same day by board member and former Allegro MicroSystems chief executive Vineet Nargolwala, who will guide the company as it integrates Honeywell’s Productivity Solutions and Services business. This leadership change places a veteran technology and Honeywell alumnus at the helm just as Brady undertakes one of its most complex acquisitions. We’ll now examine how appointing Vineet...

Caledonia Mining (NYSEAM:CMCL) has reported significant exploration results from its Motapa property in Zimbabwe, confirming substantial gold mineralisation across several zones. Motapa is located directly adjacent to the Bilboes Gold Project, pointing to possible extensions of existing mineralised structures and future operational synergies. A maiden resource estimate for Motapa is scheduled for Q3, which could be an important milestone for how investors assess the company’s gold resource...

Pinnacle West Capital recently completed a US$499.58 million fixed‑income offering of 4.650% senior unsecured notes due June 1, 2029, following the closure of a US$40.75 million dividend reinvestment common stock shelf and ahead of a special call held on June 8, 2026. Together, the sizable debt issuance, prior equity program completion, and subsequent special call highlight an active period of balance sheet planning that may shape how investors interpret the company’s capital plans and...

Establishment Labs Holdings (ESTA) has drawn fresh attention after recent share price moves, with the stock up about 11% over the past month and roughly 25% in the past 3 months. See our latest analysis for Establishment Labs Holdings. The recent 7 day share price return of 9.74% and 90 day share price return of 24.95% come on top of a 1 year total shareholder return of 106.18%, pointing to momentum that has been building rather than fading. If you are comparing ESTA with other faster growing...

Earlier this week, Vornado Realty Trust reported that PENN 2 in New York’s PENN DISTRICT is now 90% leased after signing 10–12 year full-floor agreements with technology tenants Veeva and Altana AI, which is establishing its new headquarters there. This leasing progress at a flagship redevelopment, coupled with increased interest across office REITs, highlights how high-quality, amenity-rich assets may be attracting tenants even as the broader office sector adjusts to new working...

CG Oncology (CGON) is back in focus as investors look ahead to key data from its Phase 3 PIVOT-006 trial and a planned regulatory filing for bladder cancer therapy cretostimogene later this year. See our latest analysis for CG Oncology. Recent excitement around cretostimogene and upcoming conference appearances has not prevented some volatility, with the share price down 20.77% over the past month and 12.78% over 90 days, yet still posting a 31.42% year to date share price return and a very...

In recent days, Clear Street analyst Tim Moore highlighted Willdan Group’s potential upside, citing expected revenue and adjusted EBITDA growth from power grid modernization and rising demand for energy-efficient and AI datacenter solutions, while company insiders sold about US$6.1 million of stock over the past three months. This combination of bullish analyst commentary on AI datacenter exposure and concurrent insider selling offers a contrasting signal about management’s and the market’s...

Over the last 7 days, the United States market has experienced a 4.1% drop, yet it remains up by 21% over the past year with anticipated earnings growth of 18% per annum in the coming years. In this fluctuating environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Over the last 7 days, the United States market has experienced a 4.1% drop, yet it remains up by 21% over the past year with earnings forecasted to grow by 18% annually. In this context of fluctuating market conditions, companies with high insider ownership and strong revenue growth potential can offer intriguing opportunities for investors seeking stability and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped by 4.1%, though it has risen by an impressive 21% over the past year, with earnings forecasted to grow annually by 18%. In this dynamic environment, identifying dividend stocks that offer reliable income and potential for growth can be a prudent strategy for investors seeking stability amidst market fluctuations.

EHang Holdings Limited reported weaker Q1 2026 results on June 9, with CNY 25.66 million in sales and a CNY 125.96 million net loss, while reaffirming its 2026 revenue guidance of RMB 600 million. Alongside these results, the company authorized a new US$30 million share repurchase program funded from existing cash, signaling management’s confidence as it advances pilotless eVTOL commercialization. We’ll now examine how reaffirmed 2026 revenue guidance, despite soft Q1 sales, affects EHang’s...

Global growth warnings, inflation pressures, and conflict driven supply risks are pushing commodity and natural resource stocks back into the spotlight. With the World Bank projecting 2.5% global growth for 2024 and highlighting the risk of sharper slowdowns, investors are again weighing how exposure to energy, materials, and agriculture related businesses might respond to higher price volatility and prolonged tight financial conditions. This article highlights three large, financially stable...

In early June 2026, OPKO Health amended its agreement with Nicoya Therapeutics, securing a 15% equity stake while preserving eligibility for up to US$115 million in potential RAYALDEE-related payments in Greater China and surrounding territories. This deeper Nicoya partnership adds an ownership position on top of royalties and milestones, tying OPKO Health more directly to RAYALDEE’s regional commercialization outcomes. Next, we’ll examine how OPKO’s new 15% Nicoya stake and reshaped...

JBS (JBS) has drawn fresh attention after its shares fell 5.1%, leaving the stock down 22.1% over the past month while value models now classify it as significantly undervalued. See our latest analysis for JBS. Recent news has been mixed for JBS, with operational updates such as automation contracts at a JBS Group poultry processor and local real estate moves sitting alongside a sharp 30 day share price return of down 22.8%. This leaves the year to date share price return at down 15.2% and...

KKR (NYSE:KKR) is leading a consortium in advanced talks to acquire DCC in a deal valued at over £5b. The potential transaction would be one of the largest European energy distribution deals in 2026. The consortium has reportedly sweetened its offer as negotiations progress. For you as an investor, this deal sits at the intersection of private equity and energy infrastructure, an area drawing more attention as capital targets utilities and distribution assets. KKR is already a large global...

Permian Resources (NYSE:PR) is being affected by escalating conflict in the Middle East and U.S. military action related to Iran. Partial closure of the Strait of Hormuz is disrupting oil flows and contributing to sharp oil price swings. These developments are creating new supply and pricing risks for global energy markets beyond routine company updates. Permian Resources focuses on oil and gas production from the Permian Basin, so shifts in global supply routes and benchmark prices can...

Chewy (CHWY) opened Q1 2027 with revenue of about US$3.4b and net income of US$94.8m, translating to basic EPS of US$0.23, setting a clear benchmark for how the pet retailer is currently converting sales into profit. The company reported revenue of US$3.1b in Q1 2026 and US$3.4b in Q1 2027, while basic EPS over the same quarters moved from US$0.15 to US$0.23, against a backdrop of trailing earnings growth and a current share price around US$19.98. For investors, a central question is how...